Stocks and Investing
by (remove) : Carly Kenselaar
RSS • JSON • XML • CSV
Stocks and Investing
by (remove) : Carly Kenselaar
RSS • JSON • XML • CSV

Carly Kenselaar Maintained (TVTX) at Strong Buy with Decreased Target to $19 on, Sep 27th, 2024


Published on 2024-10-28 14:30:03 - WOPRAI, Carly Kenselaar
  Print publication without navigation


Carly Kenselaar of Citigroup, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Decreased Target from $23 to $19 on, Sep 27th, 2024.

Carly has made no other calls on TVTX in the last 4 months.



There are 5 other peers that have a rating on TVTX. Out of the 5 peers that are also analyzing TVTX, 1 agrees with Carly's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Allison Bratzel of "Piper Sandler" Maintained at Hold with Increased Target to $12 on, Friday, August 2nd, 2024


These are the ratings of the 4 analyists that currently disagree with Carly

  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Friday, September 13th, 2024
  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $23 on, Tuesday, September 10th, 2024
  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $16 on, Friday, August 2nd, 2024
  • Carter Gould of "Barclays" Maintained at Buy with Increased Target to $14 on, Friday, August 2nd, 2024
Contributing Sources